INSM Jul 2024 20.000 put
| Previous Close | 0.0500 |
| Open | 0.2000 |
| Bid | 0.0000 |
| Ask | 0.1000 |
| Strike | 20.00 |
| Expire Date | 2024-07-19 |
| Day's Range | 0.0300 - 0.2500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 21.79k |
ZacksInsmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Data from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes of worsening disease symptoms in patients with bronchiectasis, a chronic lung condition.
Investing.comInsmed PT Raised to $67 at TD Cowen
TD Cowen analysts raised the price target on Insmed (NASDAQ:INSM) to $67.00 (from $45.00) while maintaining a Buy rating.
PR NewswireInsmed Announces Proposed $500 Million Public Offering of Common Stock
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it intends to offer and sell $500 million of shares of its common stock in an underwritten public offering. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. All of the shares to be sold in the offering are to
